Eris Lifesciences Disrupts the GLP-1 Market with ₹...
Category : ODD/BTA/FTA Status 23 March 2026The semaglutide price war in India just hit a new low. Eris Lifesciences Limited has launched its ge...
The semaglutide price war in India just hit a new low. Eris Lifesciences Limited has launched its ge...
Sanofi announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy des...
Hemab Therapeutics has received a major regulatory boost after the U.S. Food and Drug Administration...
Veloxis Pharmaceuticals, Inc., a global specialty pharmaceutical company and part of Asahi Kasei Cor...
Ionis Pharmaceuticals has achieved a major regulatory milestone with the U.S. FDA granting Breakthro...